Mouwasat Medical Services Co. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

884.55

777.32

796.35

764.35

755.55

710.74

690.30

Other Operating Income

0.00

Total Operating income

884.55

777.32

796.35

764.35

755.55

710.74

690.30

Raw Material Cost

550.28

453.74

439.94

417.15

437.78

392.81

382.86

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

3.84

4.57

5.42

5.72

6.66

7.24

8.01

Selling and Distribution Expenses

86.73

114.30

153.70

137.29

134.07

153.59

131.92

Other Expenses

-0.38

-0.46

-0.54

-0.57

-0.67

-0.72

-0.80

Total Expenditure (Excl Depreciation)

637.01

568.04

593.63

554.44

571.84

546.40

514.78

Operating Profit (PBDIT) excl Other Income

247.5

209.3

202.7

209.89999999999998

183.70000000000002

164.3

175.5

Other Income

9.26

7.34

6.59

10.08

5.40

6.16

3.20

Operating Profit (PBDIT)

315.61

278.28

271.77

281.45

249.62

230.53

237.77

Interest

3.84

4.57

5.42

5.72

6.66

7.24

8.01

Exceptional Items

0.00

-0.00

0.00

Gross Profit (PBDT)

334.27

323.59

356.42

347.20

317.77

317.93

307.43

Depreciation

58.81

61.66

62.46

61.46

60.52

60.02

59.05

Profit Before Tax

252.97

212.05

203.88

214.27

182.44

163.27

170.70

Tax

7.54

4.96

8.93

9.71

1.48

9.05

11.84

Provisions and contingencies

0.00

Profit After Tax

238.37

199.66

186.97

197.05

171.84

149.64

152.70

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

238.37

199.66

186.97

197.05

171.84

149.64

152.70

Share in Profit of Associates

0.00

Minority Interest

7.06

7.43

7.99

7.52

7.84

4.57

6.17

Other related items

0.00

Consolidated Net Profit

245.43

207.09

194.95

204.57

179.68

154.21

158.86

Equity Capital

0.00

Face Value

10.0

Reserves

3,778.00

3,752.01

3,552.35

3,765.39

3,568.34

3,400.98

3,251.33

Earnings per share (EPS)

1.19

1.0

0.93

0.99

0.86

0.75

0.76

Diluted Earnings per share

1.19

1.0

0.93

0.99

0.86

0.75

0.76

Operating Profit Margin (Excl OI)

27.99%

26.92%

25.46%

27.46%

24.31%

23.12%

25.43%

Gross Profit Margin

35.25%

35.21%

33.45%

36.07%

32.16%

31.42%

33.28%

PAT Margin

26.95%

25.69%

23.48%

25.78%

22.74%

21.05%

22.12%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 17.09% vs -2.28% in Dec 2024

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 36.56% vs -6.65% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 25.47% vs -5.82% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -43.28% vs -42.74% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Mouwasat Medical Services Co. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(SAR)

Change(%)

Net Sales

884.55

Other Operating Income

0.00

Total Operating income

884.55

Raw Material Cost

550.28

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

3.84

Selling and Distribution Expenses

86.73

Other Expenses

-0.38

0.00

-0.38

Total Expenditure (Excl Depreciation)

637.01

Operating Profit (PBDIT) excl Other Income

247.54

0.00

247.54

Other Income

9.26

Operating Profit (PBDIT)

315.61

Interest

3.84

Exceptional Items

0.00

Gross Profit (PBDT)

334.27

Depreciation

58.81

Profit Before Tax

252.97

Tax

7.54

Provisions and contingencies

0.00

Profit After Tax

238.37

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

238.37

Share in Profit of Associates

0.00

Minority Interest

7.06

Other related items

0.00

Consolidated Net Profit

245.43

Equity Capital

0.00

Face Value

10.00

0.00

Reserves

3,778.00

Earnings per share (EPS)

1.19

Diluted Earnings per share

1.19

Operating Profit Margin (Excl OI)

27.99%

0.00

27.99%

Gross Profit Margin

35.25%

0.00

35.25%

PAT Margin

26.95%

0.00

26.95%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 88.46 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 13.80% vs -2.40% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 17.09% vs -2.28% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 24.54 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 18.49% vs 6.21% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 36.56% vs -6.65% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 30.64 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 13.10% vs 2.15% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 25.47% vs -5.82% in Dec 2024

Quarterly - Interest

Interest 0.38 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -17.39% vs -14.81% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -43.28% vs -42.74% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 27.99%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024